State Medicaid programs for low-income families are the single biggest source of coverage, giving 31.6 million people access ...

U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the ...

State Medicaid programs for low-income families are the single biggest source of coverage, giving 31.6 million people access ...

Ozempic, Wegovy and other GLP-1 drugs have been shown to curb alcoholism, a new study suggests. Researchers explain why ...

In the United Kingdom, the government is hoping weight loss drugs might improve public finances, eyeing their use to help ...

Research shows that 1 in 8 adults in the US has used one of the popular GLP-1 medications, most of them trying to manage ...

Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out ...

Sanjay Gupta, CNN’s chief medical correspondent, explains the effect weight loss drugs can have on your body. China's Xi ...

As optimism for GLP-1 receptor agonists for weight loss has grown, so too has their use in children. Currently, liraglutide ...

The use of weight loss drugs without doctor's supervision is not advisable and can lead to serious side effects and ...

From constipation to muscle loss, the side effects of some weight loss and diabetes medications can be daunting to patients.

Researchers looked at the health records of 17 million Americans with obesity and determined that between 2022 and 2023, ...